Cytek Biosciences, Inc. CTKB Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenue, net by Geography | ||||||
| APAC | $7.75M-41.2% | $13.18M+18.3% | $11.14M+41.6% | $7.87M-11.5% | $8.89M-22.7% | |
| China | $3.6M-42.9% | $6.3M+18.9% | $5.3M+47.2% | $3.6M-32.1% | $5.3M— | |
| EMEA | $10.77M-45.1% | $19.62M+58.4% | $12.39M+0.6% | $12.31M+6.4% | $11.57M-28.6% | |
| Other | $1.23M-66.9% | $3.72M+138% | $1.56M+2.1% | $1.53M-37.8% | $2.47M-53.2% | |
| United States | $24.4M-4.8% | $25.62M-5.8% | $27.2M+13.8% | $23.9M+28.9% | $18.54M-24.4% | |
| Total by Geography | ||||||
| APAC | $9.52M-0.9% | $9.61M-0.1% | $9.62M+1.1% | $9.52M+2.5% | $9.28M-0.2% | |
| EMEA | $436K+2.6% | $425K-4.7% | $446K-5.3% | $471K+11.6% | $422K-3.0% | |
| United States | $10.52M+31.8% | $7.98M0.0% | $7.98M-4.6% | $8.37M+2.9% | $8.13M-1.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cytek Biosciences, Inc. break its business down?
- Cytek Biosciences, Inc. (CTKB) reports total revenue, net by geography across 5 parts — APAC, China, EMEA, Other and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Cytek Biosciences, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cytek Biosciences, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
